| OALBE0603 | Costs and cost-effectiveness of immediate initiation of antiretroviral therapy upon diagnosis of HIV (Rapid Start) in the United States | Oral abstract session with live Q&A | Costing, cost effectiveness and affordability |
| OALBE0604 | Feasibility and acceptability of delivering event driven PrEP (9ED-PrEP) to prevent HIV among MSM: a pilot project in Harare, Zimbabwe | Oral abstract session with live Q&A | Implementation science and scale up of prevention |
| OALBE0605 | Key population-led same-day antiretroviral therapy initiation hubs in Bangkok, Thailand: an evaluation of HIV cascade outcomes from a hybrid type 3 implementation-effectiveness trial | Oral abstract session with live Q&A | Implementation science and scale up of treatment |
| OALBX0102 | Doravirine/Islatravir (100mg/0.75mg) once daily compared to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as Initial HIV-1 treatment: 48 week results from a double-blind phase 3 trial | Oral abstract session with live Q&A | Antiretroviral therapies and clinical issues in adults |
| OALBX0103 | A social network-based intervention increases HIV self-testing and linkage to health facilities among fishermen in Kenya | Oral abstract session with live Q&A | Population-specific interventions for HIV prevention |
| OALBX0104 | Sustained aviraemia in the absence of anti-retroviral therapy in male children following in utero vertical HIV transmission | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |
| OALBX0105 | Socioeconomic support to improve completion of tuberculosis preventive therapy among adults starting HIV treatment in Tanzania: a quasi-cluster randomized trial | Oral abstract session with live Q&A | Integration of HIV services with other health and support services |
| OALBX0202 | Positive Predictive Value of HIV Serological Tests in HPTN 084 Trial | Oral abstract session with live Q&A | HIV testing |
| OALBX0203 | Initial PrEP product choice: results from the HPTN 084 open-label extension | Oral abstract session with live Q&A | HIV prevention research |
| OALBX0204 | Racial disparities in HIV incidence and PrEP non-adherence among gay and other men who have sex with men (MSM) and transgender women (TGW) using oral PrEP in Brazil: ImPrEP Study | Oral abstract session with live Q&A | HIV prevention research |